RI
Rigel Pharma
RIGL·NASDAQS San Francisco CAFounded 1996200 employees
Small CapbiotechPublicHematology
Platform: Fostamatinib
Market Cap
$0.3B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (RIGL)
Loading RIGL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Ribocilimab | RIG-8720 | Phase 3 | 4 | CDK4/6 | Wilms | ||
| Bemacapivasertib | RIG-9549 | Phase 2 | 1 | IL-23 | FLNSCLC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)